Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOXORUBICIN for Hypercholesterolaemia: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 5 adverse event reports in the FDA FAERS database where DOXORUBICIN was used for Hypercholesterolaemia.

Most Reported Side Effects for DOXORUBICIN

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 8,844 10.7% 1,075 5,491
Off label use 7,858 9.5% 1,712 2,385
Disease progression 6,165 7.5% 1,384 865
Neutropenia 5,891 7.1% 927 2,104
Drug ineffective 4,598 5.6% 1,342 1,068
Pyrexia 3,697 4.5% 482 2,503
Thrombocytopenia 3,638 4.4% 645 1,330
Anaemia 3,601 4.4% 555 1,566
Product use in unapproved indication 3,502 4.2% 821 978
Nausea 2,925 3.5% 279 1,405
Sepsis 2,740 3.3% 1,481 1,198
Pneumonia 2,611 3.2% 839 1,521
Death 2,515 3.0% 2,514 299
Diarrhoea 2,330 2.8% 403 1,216
Vomiting 2,279 2.8% 310 1,233

Other Indications for DOXORUBICIN

Diffuse large b-cell lymphoma (15,213) Product used for unknown indication (5,186) Hodgkin's disease (4,606) B-cell lymphoma (3,947) Breast cancer (3,641) Non-hodgkin's lymphoma (3,298) Acute lymphocytic leukaemia (3,128) Plasma cell myeloma (2,820) Chemotherapy (1,756) Ovarian cancer (1,692)

Other Drugs Used for Hypercholesterolaemia

EVOLOCUMAB (23,505) ATORVASTATIN (5,615) ALIROCUMAB (4,924) SIMVASTATIN (3,010) ROSUVASTATIN (2,690) EZETIMIBE (1,589) PRAVASTATIN (764) INCLISIRAN (486) FENOFIBRATE (286) FLUVASTATIN (264)

Related Pages

DOXORUBICIN Full Profile All Hypercholesterolaemia Drugs DOXORUBICIN Demographics DOXORUBICIN Timeline